ofa lawsuit semaglutide OFA Files Another Lawsuit Against

Au HCT, Lam PH, Lim PK, McIntyre RS (2025) Role of Glucagon-Like Peptide-1 on Amyloid, Tau, and -Synuclein: Target Engagement and Rationale for the Development in Neurodegenerative Disorders

The pharmacological profile of GLP-1 agonists extends beyond diabetes management

While issues like nausea, constipation, cramping, headache, heartburn, and dizziness are frequently discussed, the experience of fatigue, particularly with semaglutide, is a noteworthy side effect that is perhaps less universally highlighted

For comprehensive safety information, review our guide on IV therapy safety

Brown TD, Whitehead KA, Mitragotri S

It can lead to shocks and pain, especially when walking or standing for long periods